Petal Consortium

Jain Lab

About Us

Study Details

News Center

For Healthcare Professionals

Participating Centers

Support Us

Jain lab

Presentations

Oral presentations

Is There a Role for MRD in Predicting Outcome Post Transplant? Presented by Dr. Salvia Jain.

Dr Salvia Jain

Is There a Role for MRD in Predicting Outcome Post Transplant? Presented by Dr. Salvia Jain.

Dr Salvia Jain

Is There a Role for MRD in Predicting Outcome Post Transplant? Presented by Dr. Salvia Jain.

Dr Salvia Jain

PETAL Consortium: Transforming the Tc-Cell Lymphoma Research Landscape Presented by Forum Bhanushali

Forum Bhanushali

PETAL Consortium: Transforming the Tc-Cell Lymphoma Research Landscape Presented by Forum Bhanushali

Forum Bhanushali

PETAL Consortium: Transforming the Tc-Cell Lymphoma Research Landscape Presented by Forum Bhanushali

Forum Bhanushali

Integrative Analysis of Histone Modifications and 3D Chromatin Organization Reveals Altered Epigenetic Landscapes across T-Cell Lymphoma Subtypes Presented by Caroline MacVicar

Caroline MacVicar

Integrative Analysis of Histone Modifications and 3D Chromatin Organization Reveals Altered Epigenetic Landscapes across T-Cell Lymphoma Subtypes Presented by Caroline MacVicar

Caroline MacVicar

Integrative Analysis of Histone Modifications and 3D Chromatin Organization Reveals Altered Epigenetic Landscapes across T-Cell Lymphoma Subtypes Presented by Caroline MacVicar

Caroline MacVicar

Global patterns of care in PTCL, Presented by: Salvia Jain

Dr Salvia Jain

Global patterns of care in PTCL, Presented by: Salvia Jain

Dr Salvia Jain

Global patterns of care in PTCL, Presented by: Salvia Jain

Dr Salvia Jain

Incorporation of Novel Causal Inference Methods to Define Impact of Therapy Sequences in Relapsed and Refractory Mature T- and NK-Cell Neoplasms: A Global Study of the PETAL Consortium, Presented by: Mark N Sorial

Mark Sorial

Development of a Novel Prognostic Score for Relapsed/Refractory Mature T-Cell and NK-Cell Lymphomas (PIRT): Results from a Global Peripheral T-Cell Lymphoma (PETAL) Consortium

Angela Koh

Development of a Novel Prognostic Score for Relapsed/Refractory Mature T-Cell and NK-Cell Lymphomas (PIRT): Results from a Global Peripheral T-Cell Lymphoma (PETAL) Consortium

Angela Koh

Development of a Novel Prognostic Score for Relapsed/Refractory Mature T-Cell and NK-Cell Lymphomas (PIRT): Results from a Global Peripheral T-Cell Lymphoma (PETAL) Consortium

Angela Koh

B. Poster presentations

Unveiling the Tumor Microenvironment in Extranodal NK/T-Cell Lymphoma (ENKTCL) Patients with in Situ Spatial Transcriptomics

Dimitra Karagkouni

Unveiling the Tumor Microenvironment in Extranodal NK/T-Cell Lymphoma (ENKTCL) Patients with in Situ Spatial Transcriptomics

Dimitra Karagkouni

Unveiling the Tumor Microenvironment in Extranodal NK/T-Cell Lymphoma (ENKTCL) Patients with in Situ Spatial Transcriptomics

Dimitra Karagkouni

Real-World Evidence for Duvelisib and Romidepsin Combination in Patients with Relapsed/Refractory Peripheral T-Cell Lymphomas

Josie Ford

Real-World Evidence for Duvelisib and Romidepsin Combination in Patients with Relapsed/Refractory Peripheral T-Cell Lymphomas

Josie Ford

Real-World Evidence for Duvelisib and Romidepsin Combination in Patients with Relapsed/Refractory Peripheral T-Cell Lymphomas

Josie Ford

Integrative Analysis of 3D Chromatin Organization Revealed Regulation Mechanisms in Angioimmunoblastic T-Cell Lymphoma

Makoto Iwasaki

Integrative Analysis of 3D Chromatin Organization Revealed Regulation Mechanisms in Angioimmunoblastic T-Cell Lymphoma

Makoto Iwasaki

Integrative Analysis of 3D Chromatin Organization Revealed Regulation Mechanisms in Angioimmunoblastic T-Cell Lymphoma

Makoto Iwasaki

Integrated Omics to Dissect the Landscape in Chemosensitive and Refractory Extranodal Natural-Killer T-Cell Lymphoma (ENKTCL): A Global Study of the PETAL (PEripheral T-Cell Lymphoma) Consortium Presented by Alexandra Lenart

Alexandra Lenart

Real-World Evidence of Duvelisib and Romidepsin Combination in Relapsed/Refractory (R/R) Peripheral and Cutaneous T-Cell Lymphomas Presented by Kusha Chopra

Kusha Chopra

Real-World Evidence of Duvelisib and Romidepsin Combination in Relapsed/Refractory (R/R) Peripheral and Cutaneous T-Cell Lymphomas Presented by Kusha Chopra

Kusha Chopra

Real-World Evidence of Duvelisib and Romidepsin Combination in Relapsed/Refractory (R/R) Peripheral and Cutaneous T-Cell Lymphomas Presented by Kusha Chopra

Kusha Chopra

Integrated Omics to Dissect the Landscape in Chemosensitive and Refractory Extranodal Natural-Killer T-Cell Lymphoma (ENKTCL): A Global Study of the PETAL (Peripheral T-Cell Lymphoma) Consortium, Presented by: Sean M McCabe

Sean McCabe

Integrative analysis of 3D chromatin organization reveals regulation mechanisms in angioimmunoblastic T-cell lymphoma, Presented by: Caroline MacVicar

Caroline MacVicar

Integrative analysis of 3D chromatin organization reveals regulation mechanisms in angioimmunoblastic T-cell lymphoma, Presented by: Caroline MacVicar

Caroline MacVicar

Integrative analysis of 3D chromatin organization reveals regulation mechanisms in angioimmunoblastic T-cell lymphoma, Presented by: Caroline MacVicar

Caroline MacVicar

Molecular Residual Disease Detection via CAPP-Seq in Patients with PTCL Undergoing Autologous Stem Cell Transplantation, Presented by: Josie Ford

Josie Ford

Molecular Residual Disease Detection via CAPP-Seq in Patients with PTCL Undergoing Autologous Stem Cell Transplantation, Presented by: Josie Ford

Josie Ford

Molecular Residual Disease Detection via CAPP-Seq in Patients with PTCL Undergoing Autologous Stem Cell Transplantation, Presented by: Josie Ford

Josie Ford

Real-World Evidence for Devlisib and Romidepsin Combination in Patients with Relapsed/Refractory (R/R) Peripheral T-cell Lymphoma, Presented by: Josie Ford

Josie Ford

Real-World Evidence for Devlisib and Romidepsin Combination in Patients with Relapsed/Refractory (R/R) Peripheral T-cell Lymphoma, Presented by: Josie Ford

Josie Ford

Real-World Evidence for Devlisib and Romidepsin Combination in Patients with Relapsed/Refractory (R/R) Peripheral T-cell Lymphoma, Presented by: Josie Ford

Josie Ford

Study details

Our Study

Flow Chart

Study Synopsis

News center

Consortium Highlights & Events

Publications

Presentations

Social Media

For healthcare professionals

PIRT Calculator

Participating Sites Login

Study details

Our Study

Flow Chart

Study Synopsis

News center

Consortium Highlights & Events

Publications

Presentations

Social Media

For healthcare professionals

PIRT Calculator

Participating Sites Login

Study details

Our Study

Flow Chart

Study Synopsis

News center

Consortium Highlights & Events

Publications

Presentations

Social Media

For healthcare professionals

PIRT Calculator

Participating Sites Login

Presentations

Presentations

Oral presentations

Dr Salvia Jain

Dr Salvia Jain

Dr Salvia Jain

Forum Bhanushali

Forum Bhanushali

Forum Bhanushali

Caroline MacVicar

Caroline MacVicar

Caroline MacVicar

Dr Salvia Jain

Dr Salvia Jain

Dr Salvia Jain

Mark Sorial

Mark Sorial

Mark Sorial

Angela Koh

Angela Koh

Angela Koh

B. Poster presentations

Dimitra Karagkouni

Dimitra Karagkouni

Dimitra Karagkouni

Josie Ford

Josie Ford

Josie Ford

Makoto Iwasaki

Makoto Iwasaki

Makoto Iwasaki

Alexandra Lenart

Alexandra Lenart

Alexandra Lenart

Kusha Chopra

Kusha Chopra

Kusha Chopra

Sean McCabe

Sean McCabe

Sean McCabe

Caroline MacVicar

Caroline MacVicar

Caroline MacVicar

Josie Ford

Josie Ford

Josie Ford

Josie Ford

Josie Ford

Josie Ford

Menu

Study details

News center

For healthcare professionals

Menu

Study details

News center

For healthcare professionals

Menu

Study details

News center

For healthcare professionals